Icotrokinra for treating moderate to severe plaque psoriasis in people 12 years and over [ID6579]

  • In development
  • GID-TA11780
  • Expected publication date: TBC
To appraise the clinical and cost effectiveness of Icotrokinra within its marketing authorisation for treating plaque psoriasis ID6579